Header links
Intranet
Donate now
image/svg+xml Map
Contact us

Maria Teresa Mateu Peláez

Maria Teresa Mateu Peláez

Institutions of which they are part

Predoctoral researcher
Headache and Neurological Pain
Vall Hebron Institut de Recerca
Maria Teresa Mateu Peláez

Maria Teresa Mateu Peláez

Maria Teresa Mateu Peláez

Institutions of which they are part

Predoctoral researcher
Headache and Neurological Pain
Vall Hebron Institut de Recerca

Related news

Equip del grup de Cefalea i Dolor Neurològic del VHIR

Early initiation of specific treatment for migraine improves the course of the disease

Two international studies led by Vall d'Hebron recommend early administration of specific drugs to prevent migraine to achieve a better response to therapy.

Pacient d'un assaig clínic a la consulta

VHIR exceeds 700 active clinical trials to achieve new therapies for patients

On World Clinical Trials Day, we highlight some of the studies we have participated in that confirm the efficacy of new drugs, allowing their approval by regulatory agencies.

Patricia Pozo

A trial demostrates the efficacy of an oral drug for the prevention of chronic migraine

The study, conducted in more than 770 people, concludes that atogepant reduces the frequency of migraine attacks and the need to take medication.

See more

Related professionals

Jorge Pérez López

Jorge Pérez López

Genetics Medicine
Read more
Marta Sanchiz Cruz

Marta Sanchiz Cruz

Research technician
Infectious Diseases
Read more
M. Mercè Fabregat Bosch

M. Mercè Fabregat Bosch

Reconstructive Surgery of the Locomotor System
Read more
Albert Selva O'Callaghan

Albert Selva O'Callaghan

Main researcher
Systemic Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.